Change Healthcare’s systems are down for the seventh day after a cyber threat actor gained access to its network last week. Parent company UnitedHealth Group said most U.S. pharmacies have set up electronic workarounds to mitigate the impact.
UnitedHealth discovered that a “suspected nation-state-associated” threat actor breached part of Change Healthcare’s information technology network on Wednesday, according to a filing with the U.S. Securities and Exchange Commission Thursday. UnitedHealth isolated and disconnected the impacted systems “immediately upon detection” of the threat, the filing said.
Change Healthcare offers tools for payment and revenue cycle management, and its system outages have disrupted operations in pharmacies and health systems across the country. UnitedHealth said late Monday night that more than 90% of the nation’s pharmacies have set up modified electronic claims processing workarounds, while the rest have set up offline processing systems.
The disruption has not impacted provider cash flows yet since payments are typically issued one to two weeks after processing, UnitedHealth said Monday.
UnitedHealth is the biggest health-care company in the U.S. by market cap, and it owns the health-care provider Optum, which services more than 100 million patients in the U.S., according to its website. Change Healthcare merged with Optum in 2022.
In a series of updates posted since Wednesday, Change Healthcare said it has a “high-level” of confidence that Optum, UnitedHealthcare and UnitedHealth Group’s systems were not affected by the attack. UnitedHealth said that these entities have been working with external partners like Palo Alto Networks and Google Cloud’s Mandiant to assess the breach.
“We appreciate the partnership and hard work of all of our relevant stakeholders to ensure providers and pharmacists have effective workarounds to serve their patients as systems are restored to normal,” UnitedHealth told CNBC in a statement Monday night.
Rising number of health-care cyberattacks
The attack on Change Healthcare comes after 2023 set a grim record for health-related cybercrime. There were 725 large health-care security breaches last year, up from the record 720 the previous year, according to a January report from The HIPAA Journal.
Health data is attractive to bad actors because it can be easily monetized and sold on the dark web to perpetuate other crimes like identity theft and health-care fraud, said John Riggi, national advisor for cybersecurity and risk at the American Hospital Association.
He said there are different kinds of cyberattacks impacting the health-care sector, including data theft attacks and ransomware attacks. In a data theft attack, bad actors sneak into a system and steal data. In a high-impact ransomware attack, the fallout can cause immediate harm to patients’ physical safety.
“They come in and encrypt all the data in networks, so that suddenly, immediately, systems go dark, they become unavailable,” Riggi told CNBC in an interview. This means diagnostic technologies like CT scanners can go offline, and ambulances carrying patients are often diverted, which can delay life-saving care.
UnitedHealth has not yet disclosed the nature of the attack on Change Healthcare.
“They’re a victim of a foreign-based cyberattack,” Riggi said. “Ultimately, though, this was not an attack just on them, this was an attack on the entire health-care sector.”
Health care is a complex industry with lots of moving pieces and entry points, which means it can be hard for any organization to be 100% secure, said Cliff Steinhauer, director of information security and engagement at the National Cybersecurity Alliance.
Even so, he said there are steps individuals can take to help keep their personal data safe, like keeping their software updated, setting up multi-factor authentication and using strong, unique passwords.
“We all have a job to keep ourselves safe online,” Steinhauer told CNBC in an interview.
Riggi said senior health-care leaders need to dedicate real resources to cybersecurity and understand that it presents a risk to “every function” of the organization. In addition to deploying necessary technical defenses, he said health systems need to foster cultures where everyone feels like a part of the cybersecurity team.
But when it comes to preventing cyberattacks, Riggi said offense is just as important as defense.
“This is equivalent to cyber terrorism,” he said. “The government must devote as much priority, attention and resources to going after the bad guys who are conducting these attacks.”
Impact of Change Healthcare’s breach
UnitedHealth has not specifically disclosed exactly which Change Healthcare systems have been affected, but the fallout from the cyberattack has caused a ripple of problems across the U.S. health-care system.
CVS Health said some of its business operations were impacted by the interruption in a statement to CNBC on Saturday. The company said it has been unable to process insurance claims in some cases, though it can still fill prescriptions.
There is “no indication” that its systems have been compromised, CVS Health said in the statement.
Walgreens told CNBC that its pharmacy operations and the “vast majority” of its prescriptions have not been impacted by the breach at Change Healthcare, according to a statement Monday. The company said it has procedures to process the “small percentage” of prescriptions that may experience problems.
For consumers like Cary Brazeman, the disruption has been a headache.
Brazeman tried to pick up a prescription at a Vons pharmacy in Palm Springs on Saturday, a day after seeing his dermatologist, but it was a fruitless effort. He was told that the pharmacy hadn’t received the transmission from his doctor, and even if they had, they wouldn’t have been able to run his insurance.
“I’m like, ‘Okay, what am I supposed to do now?’ and they’re like, ‘We don’t know,” Brazeman told CNBC in an interview.
By Monday, Brazeman said the pharmacy had set up a workaround that helped it communicate with some insurance companies, but not all. He said he plans to revisit his doctor on Tuesday to pick up a paper copy of his prescription for the pharmacy. He hopes they can process his insurance.
Brazeman said he has been so concerned with the logistics of retrieving his medication that he wasn’t worried, until recently, about whether his personal information was exposed in the breach. The immediate problem, he said, is getting medication to the people who need it – especially those who have conditions more serious than his own.
“I’m mobile, so I can make these rounds if necessary, and I can pay cash if necessary, but there’s a lot of people who cannot,” he said.
(L-R) Apple CEO Tim Cook, Vivek Ramaswamy and Secretary of Homeland Security Kristi Noem attend the inauguration ceremony before Donald Trump is sworn in as the 47th U.S. President in the U.S. Capitol Rotunda in Washington, D.C., on Jan. 20, 2025.
Saul Loeb | Afp | Getty Images
While the stock market broadly fared better on Monday than in the prior two trading days, Apple got hammered once again, losing 3.7%, as concerns mounted that the company will take a major hit from President Donald Trump’s tariffs.
The sell-off brings Apple’s three-day rout to 19%, a downdraft that has wiped out $638 billion in market cap.
Apple is one of the most exposed companies to a trade war, analyst say, due largely to its reliance on China, which is facing 54% tariffs. Although Apple has production in India, Vietnam and Thailand, those countries also face increased tariffs as part of Trump’s sweeping plan.
Among tech’s megacap companies, Apple is having the roughest stretch. On Monday, the only stocks to drop in that group of seven were Apple, Microsoft and Tesla.
The Nasdaq finished almost barely up on Monday after plummeting 10% last week, its worst performance in more than five years.
Analysts say Apple will likely either need to raise prices or eat additional tariff costs when the new duties come into effect. UBS analysts estimated on Monday that Apple’s highest-end iPhone could rise in price by about $350, or around 30%, from its current price of $1,199.
Barclays analyst Tim Long wrote that he expects Apple to raise prices, or the company could suffer as much as a 15% cut to earnings per share. Apple may also be able to rearrange its supply chain so that imports to the U.S. come from other countries with lower tariffs.
A customer checks Apple’s latest iPhone 16 Plus (right) and Apple’s latest iPhone 16 Pro Max (left) series displayed for sale at Master Arts Shop in Srinagar, Jammu and Kashmir, on Sept. 26, 2024.
Firdous Nazir | Nurphoto | Getty Images
President Donald Trump’s reciprocal tariffs could lead Apple to raise the price of the iPhone 16 Pro Max by as much as $350 in the U.S., UBS analysts estimated Monday.
The iPhone 16 Pro Max is Apple’s highest-end iPhone on the market, and currently retails for $1,199. UBS is predicting a nearly 30% increase in retail price for units that were manufactured in China.
Apple’s $999 phone, the iPhone 16 Pro, could see a smaller $120 price increase, if the company has it manufactured in India, the UBS analysts wrote.
Shares of Apple have plummeted 20% over the past three trading days, wiping out nearly $640 billion in market cap, on concern that Trump’s tariffs will force the company to raise prices just as consumers are losing buying power.
“Based on the checks we have done at a company level, there is a lot of uncertainty about how the increased cost sharing will be done with suppliers, the extent to which costs can be passed on to end-customers, and the duration of tariffs,” UBS analyst Sundeep Gantori wrote in the note.
Apple, which does the majority of its manufacturing in China, is one of the most exposed companies to a trade war. China has a potential incoming 54% tariff rate — before new increases were proposed Monday. Smaller tariffs were also placed on secondary production locations, such as India, Vietnam and Thailand.
JPMorgan Chase analysts predicted last week that Apple could raise its prices 6% across the world to offset the U.S. tariffs. Barclays analyst Tim Long wrote that he expects Apple to raise prices, or it could suffer as much as a 15% cut to earnings per share.
If Apple were to relocate iPhone production to the U.S. — a move that most supply chain experts say is impossible — Wedbush’s Dan Ives predicts an iPhone could cost $3,500.
Morgan Stanley analysts on Friday said Apple could absorb additional tariff costs of about $34 billion annually. They wrote that although Apple has diversified its production in recent years to additional countries — so-called friendshoring — those countries could also end up with tariffs, reducing Apple’s flexibility.
After last week’s “reciprocal tariff announcement, there becomes very little differentiation in friend shoring vs. manufacturing in China — if the product is not made in the US, it will be subject to a hefty import tariff,” Morgan Stanley wrote.
Last week, the firm estimated that Apple may raise its prices across its product lines in the U.S. by 17% to 18%. Apple could also get exemptions from the U.S. government for its products.
Kimbal Musk, co-founder of The Kitchen Community, speaks during the annual Milken Institute Global Conference in Beverly Hills, California, May 3, 2016.
Patrick T. Fallon | Bloomberg | Getty Images
Elon Musk’s younger brother, Kimbal, took to the social network X on Monday to lambaste President Donald Trump’s tariffs, calling them a “structural, permanent tax on the American consumer.” He also said Trump appears to be the “most high tax American President in generations.”
“Even if he is successful in bringing jobs on shore through the tariff tax, prices will remain high and the tax on consumption will remain the form of higher prices because we are simply not as good at making things,” Kimbal Musk wrote on X, one of the companies in his brother’s extensive portfolio.
The younger Musk owns a restaurant chain called The Kitchen, is a board member at Tesla and a former director at SpaceX and Chipotle. He has also co-founded and invested in other food and tech startups, including Square Roots, an indoor farming company, and Nova Sky Stories, a creator of drone light shows that he bought from Intel.
Elon Musk is a top advisor to Trump, overseeing the so-called Department of Government Efficiency, or DOGE, an effort to drastically cut federal spending, largely through layoffs, and consolidate or eliminate agencies and regulations. However, his relationship with some key figures in the Trump administration has been showing signs of strain in recent days as the president’s sweeping tariffs have led to a dramatic selloff in stocks, including for Tesla, which is down 42% this year and just wrapped up its worst quarter since 2022.
Over the weekend, Elon Musk took aim at Trump trade advisor Peter Navarro, disparaging his qualifications in a post on X.
“A PhD in Econ from Harvard is a bad thing, not a good thing,” Musk wrote, after Navarro told CNN on Saturday that “The market will find a bottom” and that the Dow will “hit 50,000 during Trump’s term.” It’s currently at about 38,200.
Musk also said that Navarro hasn’t built “sh—.” Navarro told CNBC on Monday that Musk is “not a car manufacturer” but rather a “car assembler,” dependent on parts from Japan, China and Taiwan.
Tesla was seeking a more moderate approach to trade and tariffs in a recent letter to the U.S. Trade Representative.
According to Federal Election Commission filings, Kimbal Musk this year has contributed funds to the Libertarian National Committee and Libertarian Party of Connecticut. In 2024, while his brother became the biggest financial backer and promoter of Trump, Kimbal donated to Unite America PAC, a group that markets itself as a “philanthropic venture fund that invests in nonpartisan election reform to foster a more representative and functional government.”
A representative for Kimbal Musk didn’t immediately respond to a request for comment.